Huaren Pharmaceutical Co (SZSE:300110) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:300110 Huaren Pharmaceutical Co Ltd SZSE:300110
55 GF Score
Price ¥2.90
GF Value ¥3.13
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Huaren Pharmaceutical Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SZSE:300110 vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Huaren Pharmaceutical Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Huaren Pharmaceutical Co Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huaren Pharmaceutical Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Huaren Pharmaceutical Co's Short Interest falls into.


SZSE:300110
55GF Score
Huaren Pharmaceutical Co Ltd SZSE:300110
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Huaren Pharmaceutical Co (SZSE:300110) Overvalued in 2026?

Based on GuruFocus' analysis, Huaren Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥2.90 is trading 7.3% below its estimated GF Value™ of ¥3.13. GuruFocus considers Huaren Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SZSE:300110:

  • Short Interest:
  • GF Value™: ¥3.13 vs. price of ¥2.90 (7.3% below fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the SZSE:300110 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Huaren Pharmaceutical Co Business Description

Address No. 187 Zhuzhou Road, Qingdao, Shandong, CHN, 266100
Huaren Pharmaceutical Co Ltd is a China-based company engaged in the manufacture, and sale of non-polyvinyl chloride and Non-PVC large capacity preparations. Its categories of products include conventional infusion, therapy infusion, and nutrition infusion. The company distributes its products in domestic market, with Northeast China as its main market.
55GF Score

Get the complete analysis for SZSE:300110

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥2.90
Price
¥3.13
GF Value